FDA issued a Warning Letter to Porton Biopharma Limited on 1/19/2017 as a result of this inspection.
483 Porton Biopharma Mar 2016
483 Porton Biopharma Mar 2016Francis Guidry FDA$119.00 - Available Now
FDA investigators audited the Porton Biopharma - Salisbury, United Kingdom facility and issued inspectional observations (via FDA 483) on 18 Mar 2016.
Add To Cart
- Category: Human Drugs
- Inspection end: 18 Mar 2016
- Location: Salisbury, United Kingdom
- FEI: 3011691465